Dr Bishal Gyawali discusses with ecancer an article from BMJ about the revolving door between the FDA and the pharmaceutical industry.

He elaborates on the potential conflicts of interest arising when an FDA employee leaves their position to immediately join the pharmaceutical industry.

Dr Gyawali further emphasises the possible bias that could emerge from an FDA regulator whose ambition is to eventually work in the pharma industry, and he suggests measures to prevent such conflicts.

https://www.bmj.com/content/386/bmj.q1418